( Image: © Shutterstock)
While stage 1 and stage 2 trials examine dose, security, typical side results and effectiveness in a little number of individuals, the key to getting a vaccine authorized is the stage 3 trial, which evaluates for vaccine effectiveness while monitoring for adverse occasions in a much bigger group of people, according to a previous Live Science report
Related: Coronavirus live updates
Moderna’s vaccine uses an innovation that hasn’t yet been used in any approved vaccines to date, however has a number of benefits, consisting of being quicker and easier to produce than traditional vaccines, Live Science previously reported.
Early results from a stage 1 trial consisting of 45 individuals suggested that the vaccine prompted an immune action and appeared safe and usually well-tolerated, according to findings published on July 14 in The New England Journal of Medicine